Prevention of acute graft-versus-host disease by monoclonal antibody to interleukin-2 receptor

Lancet. 1989 Jun 10;1(8650):1333-4. doi: 10.1016/s0140-6736(89)92732-3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Disease
  • Antibodies, Monoclonal / therapeutic use*
  • Bone Marrow Transplantation
  • Follow-Up Studies
  • Graft vs Host Disease / prevention & control*
  • Humans
  • Leukemia / surgery
  • Pilot Projects
  • Receptors, Interleukin-2 / immunology*

Substances

  • Antibodies, Monoclonal
  • Receptors, Interleukin-2